专利检索 ap:("Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.") AND inv:"FORESTA, Piero" 第 1 页

1.

发明授权
USE OF 6, 7-SUBSTITUTED 2-AMINOTETRALINES FOR THE TREATMENT OF CYTOKINE MEDIATED INFLAMMATORY CONDITIONS 有权
标题翻译：的使用6,7-取代的2-氨基萘满用于治疗的细胞因子VERMITTLETEN炎症性疾病

公开(公告)号：EP1017377B1

公开(公告)日：2001-12-05

申请号：EP98946704.8

申请日：1998-09-18

申请人： SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.

发明人： FORESTA, Piero , RUGGIERO, Vito

IPC分类号： A61K31/135

CPC分类号： A61K31/135 , Y02A50/473

摘要： 6,7-substituted 2-aminotetralines are used to treat inflammatory and/or autoimmune conditions induced by inflammatory cytokines.

2.

发明授权
OPTICALLY ACTIVE 2-AMINOTETRALINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME, ACTIVE IN PREVENTING AND TREATING SEPTIC SHOCK 失效
标题翻译：光有源2-氨基TETRA线，工艺FOR THEIR和药物组合物含有它们且可用于感染性休克的预防和治疗

公开(公告)号：EP0968174B1

公开(公告)日：2003-01-22

申请号：EP98902173.8

申请日：1998-01-28

申请人： SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.

发明人： MORETTI, Gian, Piero , FORESTA, Piero

IPC分类号： C07C217/74 , A61K31/135

CPC分类号： C07C217/74 , C07B2200/07 , C07C2602/10

摘要： S(-)-amino-6-fluoro-7-methoxytetraline, a process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock, are disclosed.

3.

发明授权
2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies 有权
标题翻译： 2-氨基-6-甲基 - 7-乙酰基四氢化萘和用于预防和炎性和/或自身免疫疾病的治疗性治疗的药物组合物

公开(公告)号：EP1017667B1

公开(公告)日：2003-11-19

申请号：EP98946706.3

申请日：1998-09-22

申请人： Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

发明人： FANTO, Nicola , MORETTI, Gian, Piero , FORESTA, Piero

IPC分类号： C07C215/48 , C07C215/52 , C07C217/60 , C07C225/20 , A61K31/135

CPC分类号： C07C215/64 , C07C217/74 , C07C225/20

摘要： 2-Aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory pathologies (particularly septic shock) and/or autoimmune pathologies in which the aetiopathogenic role of inflammatory cytokines has been ascertained.